Also listed on Euthymics Bioscience, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 26, 2027 · High confidence
20-year base term ends Apr 26, 2027
Held by Ethismos Research, Inc.
Filed Jul 18, 2013 as application 13/945,605 · Granted Dec 27, 2016
Base term, 20 years from filing
Today
2007
2027
Clock starts
Apr 26, 2007
Apr 26, 2007
Term ends
Apr 26, 2027
Apr 26, 2027
Granted
Dec 27, 2016
Dec 27, 2016
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 26, 2007, when application 11/740,667, the earliest non-provisional in its chain, was filed (this one was filed Jul 18, 2013) | Apr 26, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 26, 2027 | High confidence |
This family
| Application 11/740,667 | Abandoned not computed | not computed |
| Application PCT/US2007/010288 | PCT application no patent term | no patent term |
| Application 12/782,705 | Abandoned not computed | not computed |
| Application 13/207,279 | Abandoned not computed | not computed |
| Application 13/366,211 | Abandoned not computed | not computed |
| US 9,527,813 | this patent Apr 2027 | Apr 2027 |
| Application 15/367,718 | Abandoned not computed | not computed |
| Application 15/820,959 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 25, 2014 Reel 32761, frame 1 | Murry, Jerry A.; Simmons, Bryon; Corley, Edward G.; Xu, Feng | Merck & Co., Inc. | Assignment of Assignor's Interest |
| Apr 25, 2014 Reel 32761, frame 137 | Merck & Co., Inc. | Dov Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Apr 25, 2014 Reel 32761, frame 432 | Dov Pharmaceutical, Inc. | Euthymics Bioscience, Inc. | Change of Name |
| Feb 5, 2018 Reel 45252, frame 870 | Euthymics Bioscience, Inc. | Ethismos Research, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2027
Term ends Apr 26, 2027. No further fees fall due before then
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.